New York State Common Retirement Fund
CAI

New York State Common Retirement Fund’s Caris Life Sciences CAI Stock Holding History

New York State Common Retirement Fund’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
61,300
+15,600
+34% +$279K ﹤0.01% 1709
2026
Q1 		$817K Buy
45,700
+32,800
+254% +$717K ﹤0.01% 1732
2025
Q4 		$348K Buy
+12,900
New +$363K ﹤0.01% 2091

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

New York State Common Retirement Fund's CAI Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Caris Life Sciences (CAI) stake by 34% in Q2 2026, buying an estimated $279K and bringing the position to 61,300 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

New York State Common Retirement Fund first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • New York State Common Retirement Fund held 61,300 shares of Caris Life Sciences worth $1.09M as of Q2 2026.
  • New York State Common Retirement Fund bought 15,600 Caris Life Sciences shares in Q2 2026, an estimated $279K.
  • Caris Life Sciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1709 holding.
  • New York State Common Retirement Fund first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.